To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
CHICAGO – When children present with back pain, physicians want to expose them to the least amount of medical testing without missing a diagnosis. Researchers at Children’s Hospital of Philadelphia ...
image: Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of ...
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...
The global SPECT scanning services market is poised for transformative growth, expected to reach USD 2,425.2 million by 2025 and expanding steadily at a CAGR of 4.6% to hit USD 3,819.5 million by 2035 ...
Accurate early diagnosis of acute coronary syndrome (ACS) is a challenging clinical problem. Imaging myocardial fatty acid metabolism with β-methyl-p-[123 I]-iodophenyl-pentadecanoic acid ...
The installation project also included a full renovation of the scanning room at Wellington Regional Hospital.
The current focus of cardiovascular medicine is on early detection and prevention of disease, to control the escalating costs of health care. To achieve this goal, novel imaging approaches that allow ...
GE Healthcare’s Discovery NM630 – for quicker, lower dose imaging – has just been approved by the Food and Drug Administration. This new system for disease detection and diagnosis is a SPECT scan – or ...
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...